Adverse effects on birth weight of parental illegal drug use during pregnancy and within two years before pregnancy
- PMID: 35696206
- PMCID: PMC9261820
- DOI: 10.38212/2224-6614.3355
Adverse effects on birth weight of parental illegal drug use during pregnancy and within two years before pregnancy
Abstract
This study investigates possible links between maternal illegal drug use during pregnancy and up to two years before pregnancy with birth weight (BW), and explores the potential role of paternal illegal drug use on low birth weight. A population-based retrospective cohort study was conducted that linked four national databases in Taiwan. A total of 1,698 subjects with a criminal record of schedule I or II illegal drug use within two years before pregnancy were enrolled as the drug-exposed group, and 16,980 matched subjects were enrolled as the unexposed group. Multivariate analysis of BW found a decrease of 108.63 g (95% CI: -172.29, -44.96), 79.67 g (95% CI: -116.91, -42.43), and 69.78 g (95% CI: -106.71, -32.84) in newborns whose mothers used illegal drugs only during pregnancy (period I), only within one year before pregnancy (period II), and only within the second year before pregnancy (period III), respectively. Paternal use of illegal drugs before maternal pregnancy was significantly associated with low birth weight. The paternal effect on low birth weight was opposite the maternal effect. The adverse effect of illegal drug use on birth weight existed even if the mother did not use drugs during pregnancy but had ever used drugs during the two years before pregnancy. Paternal factors' contribution to low birth weight persisted, and the decrement of BW was even greater than the maternal effect within one or two years before pregnancy. Maternal and paternal illegal drug use may have a lasting effect on their offspring's birth weight.
References
-
- United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality. National Survey on Drug Use and Health. Inter-university Consortium for Political and Social Research (ICPSR) Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor]; [Accessed 7 December 2020]. Available at . 2015, 11, 23. - DOI
-
- Fuddy LJ, Prince CB, Tang MC. Perinatal substance use among high risk women in Hawaii: Patterns and impact on pregnancy outcomes. Asian Am Pac Isl J Health. 2003;10:50–7. - PubMed
-
- Hon KL, Chan MH, Ng MH, Ho CC, Tsang KY, Tam WH, et al. Urine comprehensive drug screen, low birth weight and withdrawal symptoms in a neonatal unit: a case control study. Curr Clin Pharmacol. 2016;11:274–81. - PubMed
-
- Hulse GK, Milne E, English DR, Holman CD. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction. 1997;92:1571–9. - PubMed
-
- Miller C, Grynspan D, Gaudet L, Ferretti E, Lawrence S, Moretti F, et al. Maternal and neonatal characteristics of a Canadian urban cohort receiving treatment for opioid use disorder during pregnancy. J Dev Orig Health Dis. 2019;10:132–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources